1Subbarao K, Katz JM. Influenza vaccines generated by reverse genetics. Curr Top Microbiol Immunol, 2004,283 : 313-342.
2Kismer O, Barrett PN, Mundt W, et al. Development of a novel influenza vaccine derived from a continuous cell line. ALTEX,2001,18(1) :50-54.
3Beyer WE, Palache AM, de Jong JC, et al. Cold adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions,local and systemic antiboby response, and vaccine efficacy. A metaanalysis. Vaccine,2002.20(9-10) :1340-1353.
4Kemble G, Geenberg H, Novel generations of influenza vaccines,Vaccine, 2003,21:1789-1795.
5Jefferson T, Smith S, Demicheli V, et al, Assessment of the efficacy and effectiveness of influenza vaccines in healthy children, Lgncet, 2005, 365(9461):773-780.
6van Maanen C, van Essen GJ, Minke J, et al, Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred. Vet Mierobiol, 2003,93(4) :291-306.
7Shifting Tactics in the Battle Against Influenza. Science, 2004,30,1280
8Romanova J, Katinger D, Ferko B, et al, Live cold-adapted influenza A vaccine prioduced in veto cell line. Virus Research,2004,103:187-193.
9Youil R, Kiseleva I, Kwan W S, et al. Phenotypic and genetic of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 ( H2N2 ). Virus Research, 2004,102:165-176.
10Hoffman E, Neumann G, Kawaoka Y, et al. A DNA transfeetion system for generation of influenza A virus from eight plasmids.Proc Natl Aead Sci USA,2000, 97:6108-6113.
